2012
DOI: 10.1177/0883073812450209
|View full text |Cite
|
Sign up to set email alerts
|

Diaphragmatic Weakness With Progressive Sensory and Motor Polyneuropathy

Abstract: The authors present a child affected with diaphragmatic paralysis in the early neonatal period. Although no electroneuromyographic abnormalities were reported, the patient developed dramatic motor and respiratory impairment with impossibility to wean from mechanical ventilation. Repeated electroneuromyographic study at age 4 months revealed severe neurogenic changes and sensory nerve abnormalities with more preserved nerve conduction velocities. Genetic studies identified 2 mutations in the gene IGHMBP2. These… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
1
2

Year Published

2013
2013
2025
2025

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 15 publications
0
6
1
2
Order By: Relevance
“…4,9 We describe an infant who presented with distal weakness and primary respiratory failure associated with diaphragm paralysis but lacking a Nelson reports no disclosures relevant to the manuscript. W. Zeng is a salaried employee from Ambry Genetics, where exome sequencing is among the for-profit items on the test menu.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…4,9 We describe an infant who presented with distal weakness and primary respiratory failure associated with diaphragm paralysis but lacking a Nelson reports no disclosures relevant to the manuscript. W. Zeng is a salaried employee from Ambry Genetics, where exome sequencing is among the for-profit items on the test menu.…”
mentioning
confidence: 99%
“…4,9 We describe an infant who presented with distal weakness and primary respiratory failure associated with diaphragm paralysis but lacking a…”
mentioning
confidence: 99%
“…Variants were then filtered further based on family history and possible inheritance models. Data are annotated with the ambry variant analyzer tool (AVA), including nucleotide and amino acid conservation, biochemical nature of amino acid substitutions, population frequency (ESP and 1,000 genomes), and predicted functional impact (including PolyPhen (Gitiaux et al 2013) and SIFT (Grohmann et al 2004) in silico prediction tools). Each candidate mutation was assessed by a molecular geneticist to identify the most likely causative mutation(s).…”
Section: Methodsmentioning
confidence: 99%
“…Авторы подчеркивают, что в отличие от фенотипа при SMARD1, у 4 пациентов не выявлены нарушения дыхательной функции ни в дебюте, ни в возрасте уста-новления диагноза (14, 18, 22 и 37 лет соответственно); только у 1 пациента был отмечен дыхательный ди-стресс. В 2013 г. представлено детальное описание ребенка с прогрессирующей аксональной нейропатией с мутациями в гене IGHMBP2 [27].…”
Section: клинический разборunclassified
“…Сегодня в литературе описаны 22 пациента из 15 се мей с НМСН 2S типа с мутациями в гене IGHMBP2 [15,[25][26][27] без учета больных с пересмотренным диаг-нозом [28].…”
Section: клинический разборunclassified